Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 4 | 2024 | 265 | 2.070 |
Why?
|
| Neurovascular Coupling | 6 | 2024 | 154 | 1.890 |
Why?
|
| Peripheral Arterial Disease | 2 | 2025 | 144 | 0.810 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2023 | 14 | 0.800 |
Why?
|
| White Matter | 1 | 2023 | 90 | 0.750 |
Why?
|
| Tigers | 1 | 2021 | 1 | 0.740 |
Why?
|
| Dementia | 1 | 2023 | 95 | 0.730 |
Why?
|
| Lenses, Intraocular | 1 | 2021 | 19 | 0.720 |
Why?
|
| Phacoemulsification | 1 | 2021 | 20 | 0.720 |
Why?
|
| Hypertension | 1 | 2023 | 309 | 0.660 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2024 | 74 | 0.580 |
Why?
|
| Cognition | 4 | 2025 | 327 | 0.510 |
Why?
|
| Cerebrovascular Circulation | 4 | 2024 | 224 | 0.510 |
Why?
|
| Aged | 7 | 2025 | 5525 | 0.400 |
Why?
|
| Aging | 4 | 2024 | 979 | 0.350 |
Why?
|
| Brain | 3 | 2023 | 753 | 0.290 |
Why?
|
| Humans | 11 | 2025 | 28585 | 0.260 |
Why?
|
| Endothelium, Vascular | 2 | 2025 | 328 | 0.230 |
Why?
|
| Niacinamide | 1 | 2025 | 32 | 0.230 |
Why?
|
| Sleep Deprivation | 2 | 2021 | 28 | 0.220 |
Why?
|
| Neuropsychological Tests | 2 | 2023 | 247 | 0.220 |
Why?
|
| NAD | 1 | 2025 | 104 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 988 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2021 | 221 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 834 | 0.210 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 54 | 0.200 |
Why?
|
| Prospective Studies | 2 | 2023 | 1272 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2025 | 265 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 93 | 0.190 |
Why?
|
| Arterioles | 1 | 2022 | 61 | 0.190 |
Why?
|
| Biometry | 1 | 2021 | 20 | 0.180 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 426 | 0.180 |
Why?
|
| Refraction, Ocular | 1 | 2021 | 25 | 0.180 |
Why?
|
| Pandemics | 1 | 2023 | 196 | 0.180 |
Why?
|
| Disease Progression | 1 | 2023 | 475 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2025 | 671 | 0.180 |
Why?
|
| Cornea | 1 | 2021 | 72 | 0.180 |
Why?
|
| Motor Cortex | 1 | 2021 | 48 | 0.170 |
Why?
|
| Middle Aged | 4 | 2025 | 7310 | 0.170 |
Why?
|
| Male | 6 | 2025 | 13772 | 0.160 |
Why?
|
| Female | 5 | 2025 | 15472 | 0.130 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2612 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 2045 | 0.110 |
Why?
|
| Brain Mapping | 2 | 2021 | 207 | 0.070 |
Why?
|
| Animals | 1 | 2021 | 10583 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2025 | 27 | 0.060 |
Why?
|
| Adult | 3 | 2022 | 7922 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2025 | 190 | 0.060 |
Why?
|
| Young Adult | 2 | 2022 | 2804 | 0.050 |
Why?
|
| Fasting | 1 | 2024 | 90 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 458 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2021 | 11 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 396 | 0.040 |
Why?
|
| Reaction Time | 1 | 2021 | 95 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2021 | 50 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 62 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 80 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 136 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 732 | 0.040 |
Why?
|
| Neurons | 1 | 2021 | 291 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2019 | 51 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 770 | 0.040 |
Why?
|